Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Blood|May 22, 2009
Metnase mediates chromosome decatenation in acute leukemia cellsJustin Wray, Elizabeth A Williamson, Sheema Sheema, et al.American Journal of Clinical Oncology|November 8, 2022
Radiographic Response of Solitary Plasmacytomas After Conformal Radiotherapy May Be Delayed: Outcomes in the 3D EraSamuel Kosydar, Avanti Gulhane, Edward Libby, et al.Advances in Therapy|January 21, 2021
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab MonotherapyAjai Chari, Markus Munder, Katja Weisel, et al.Blood|July 31, 2020
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN studyConstantine S Tam, Stephen Opat, Shirley D'Sa, et al.American Journal of Hematology|March 16, 2022
Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA studyVaishali Sanchorawala, Giovanni Palladini, Monique C Minnema, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN StudyMeletios A Dimopoulos, Stephen Opat, Shirley D'Sa, et al.The Lancet. Oncology|December 21, 2019
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 studySagar Lonial, Hans C Lee, Ashraf Badros, et al.Blood Advances|February 5, 2024
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemiaConstantine S Tam, Stephen Opat, Shirley D'Sa, et al.The New England Journal of Medicine|June 30, 2021
Daratumumab-Based Treatment for Immunoglobulin Light-Chain AmyloidosisEfstathios Kastritis, Giovanni Palladini, Monique C Minnema, et al.Pageof 2